Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples